Published in

American Society of Hematology, Blood, 1(126), p. 6-7, 2015

DOI: 10.1182/blood-2015-05-643395

Links

Tools

Export citation

Search in Google Scholar

FXa variants advance toward a therapy for bleeding

Journal article published in 2015 by Jonas Emsley ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

In this issue of Blood, Ivanciu and Camire describe engineered factor (F)Xa variants with a spectrum of properties that broaden the utility of FXa as a treatment for bleeding.1.